Antibodies to vaccine-preventable infections after CAR-T-cell therapy for B-cell malignancies-Reference-Cited by-同舟云学术

Antibodies to vaccine-preventable infections after CAR-T-cell therapy for B-cell malignancies

Published:2021-04-29 Issue: Volume: Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Walti Carla S.,Krantz Elizabeth M.,Maalouf Joyce,Boonyaratanakornkit Jim^ORCID,Keane-Candib Jacob^ORCID,Joncas-Schronce Laurel,Stevens-Ayers Terry^ORCID,Dasgupta Sayan^ORCID,Taylor Justin J.^ORCID,Hirayama Alexandre V.^ORCID,Bar Merav,Gardner Rebecca A.,Cowan Andrew J.,Green Damian J.^ORCID,Boeckh Michael J.,Maloney David G.,Turtle Cameron J.,Hill Joshua A.

Funder

Swiss National Science Foundation

National Institutes of Health National Cancer Institute

NIH/NCI Cancer Center Support Grants

American Society for Transplantation and Cellular Therapy

Juno Therapeutics

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

http://insight.jci.org/articles/view/146743/files/pdf

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements and challenges in CAR T cell therapy in autoimmune diseases;Nature Reviews Rheumatology;2024-08-06

2. IgG replacement in multiple myeloma;Blood Cancer Journal;2024-07-25

3. Risk of infections with bispecific antibodies in B‐cell non‐Hodgkin lymphomas and multiple myeloma—The current state;British Journal of Haematology;2024-07-09

4. Overview of infectious complications among CAR T- cell therapy recipients;Frontiers in Oncology;2024-07-03

5. Late events after anti-CD19 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma;Frontiers in Oncology;2024-06-11